Upon treatment with IL-6, immunofluorescence studies revealed that all three lung cancer cell lines H1299, A549, and H1975 demonstrated significant alterations in the expression levels of several key markers as compared with their control counterparts. The gene discussed is IL6; the disease is lung cancer.